Lumeran, Jerald Kurt D.
HRN: 21-74-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2022
CEFTRIAXONE 1G (VIAL)
08/04/2022
08/10/2022
IV DRIP
1.5g
OD
Wbc 19. Anemia ETBD, T/C Liver Pathology
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes